As an aberrant base
in DNA, uracil is generated by either deoxyuridine
(dU) misincorporation or cytosine deamination, and involved in multiple
physiological and pathological processes. Genome-wide profiles of
uracil are important for study of these processes. Current methods
for whole-genome mapping of uracil all rely on uracil-DNA N-glycosylase
(UNG) and are limited in resolution, specificity, and/or sensitivity.
Here, we developed a UdgX cross-linking and polymerase stalling sequencing
(“Ucaps-seq”) method to detect dU at single-nucleotide
resolution. First, the specificity of Ucaps-seq was confirmed on synthetic
DNA. Then the effectiveness of the approach was verified on two genomes
from different sources. Ucaps-seq not only identified the enrichment
of dU at dT sites in pemetrexed-treated cancer cells with globally
elevated uracil but also detected dU at dC sites within the “WRC”
motif in activated B cells which have increased dU in specific regions.
Finally, Ucaps-seq was utilized to detect dU introduced by the cytosine
base editor (nCas9-APOBEC) and identified a novel off-target site
in cellular context. In conclusion, Ucaps-seq is a powerful tool with
many potential applications, especially in evaluation of base editing
fidelity.